Watching Mobia Medical, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planFunding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Back to SEC FilingsExecutive ChangeItem 5.02 · 8-KLOW RiskPositive
Mobia Medical, Inc.
Filed: Jul 14, 2026CIK: 0001489993
AI Executive Summary
AI-powered analysis of 8-K filing content
Mobia Medical expanded its Board of Directors from six to seven members by appointing Dr. Reza Zadno as a Class III independent director effective July 14, 2026, signaling a strategic effort to strengthen governance and board expertise.
Key Takeaways
Board size increased from 6 to 7 members with the appointment of Dr. Reza Zadno as Class III director
Dr. Zadno qualifies as an independent director and will serve on the Compensation Committee
2 more takeaways
Filing Overview
Form Type8-K
Filing DateJul 14, 2026
Item5.02
CategoryExecutive Change
CIK0001489993
Accession #0001489993
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board change
What This Means
A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.